Trade Mark Journal No.2026/045 6 November 2026

UK00004463484 21 October 2026 (5,42)

AMPTAC

Class 5: Biological preparations for the treatment of cancer; pharmaceuticals for the treatment of cancer; pharmaceutical preparations and substances for the prevention and treatment of cancer; small-molecule pharmaceutical preparations for the prevention and treatment of cancer; pharmaceutical preparations comprising bifunctional molecules for the prevention and treatment of cancer; pharmaceutical preparations for targeted protein degradation or protein sequestration in the treatment of cancer.
Class 42: Scientific research for medical purposes in the area of cancerous diseases; research and testing of pharmaceuticals for the treatment of cancer; drug discovery services in the area of cancerous diseases; scientific and technological research relating to the discovery and development of pharmaceuticals and therapeutic preparations; pharmaceutical research and development services; research and development of small-molecule therapeutics; identification, screening and validation of therapeutic targets, therapeutic compounds and drug candidates; research and development relating to bifunctional molecules and amplification-targeting chimeras; scientific research relating to targeted protein degradation, protein sequestration and the targeting of genomically amplified proteins in cancer cells; development of therapeutic platform technologies for the discovery and development of pharmaceuticals and therapeutic preparations; provision of scientific information and consultancy relating to pharmaceutical research, drug discovery and the development of therapeutic preparations; all of the aforesaid in the fields of cancer and oncology.

Econic Biosciences Limited

Representative: Potter Clarkson LLP